Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

Bibliographic Details
Main Authors:	Vincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, Ciro Cipullo, Andrea Paccone, Antonio Barbieri, Giuseppe Palma, Antonio Luciano, Simona Buccolo, Irma Bisceglia, Maria Laura Canale, Giuseppina Gallucci, Alessandro Inno, Claudia De Lorenzo, Nicola Maurea
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	immunotherapy biomarkers preclinical study mechanisms inflammation interleukin
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1129873/full

Similar Items

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways
by: Vincenzo Quagliariello, et al.
Published: (2022-09-01)

Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology
by: V. Quagliariello, et al.
Published: (2024-01-01)

PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
by: Vincenzo Quagliariello, et al.
Published: (2023-02-01)

Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
by: Vincenzo Quagliariello, et al.
Published: (2020-10-01)

Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis
by: Margherita Passariello, et al.
Published: (2021-08-01)

EDA-containing fibronectin increases proliferation of embryonic stem cells.
by: Noelia Losino, et al.
Published: (2013-01-01)

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
by: Margherita Passariello, et al.
Published: (2019-08-01)

A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies
by: Lorenzo Manna, et al.
Published: (2023-11-01)

New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC
by: Rosa Rapuano Lembo, et al.
Published: (2022-10-01)

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
by: Margherita Passariello, et al.
Published: (2020-02-01)

Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments
by: Cinzia Vetrei, et al.
Published: (2021-06-01)

EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer.
by: Stephanie Rossnagl, et al.
Published: (2016-09-01)

Membrane interactions of S100A12 (Calgranulin C).
by: Assuero F Garcia, et al.
Published: (2013-01-01)

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays
by: Margherita Passariello, et al.
Published: (2023-06-01)

Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC
by: Cinzia Vetrei, et al.
Published: (2021-12-01)

Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo
by: Margherita Passariello, et al.
Published: (2022-09-01)

Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression
by: Alessandro Malara, et al.
Published: (2022-09-01)

Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains.
by: Rhiannon Kelsh, et al.
Published: (2014-01-01)

Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
by: Margherita Passariello, et al.
Published: (2022-03-01)

High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand
by: Nicola Zambrano, et al.
Published: (2022-03-01)

Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model
by: Maria Vitale, et al.
Published: (2022-05-01)

Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
by: Margherita Passariello, et al.
Published: (2019-09-01)

Coevolution of the Toll-Like Receptor 4 Complex with Calgranulins and Lipopolysaccharide
by: Andrea N. Loes, et al.
Published: (2018-02-01)

Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population
by: Chen L, et al.
Published: (2022-06-01)

A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab
by: Margherita Passariello, et al.
Published: (2022-05-01)

Design and Evaluation of a Polypeptide that Mimics the Integrin Binding Site for EDA Fibronectin to Block Profibrotic Cell Activity
by: Lin Zhang, et al.
Published: (2021-02-01)

Fibronectin extra domain A (FN-EDA) causes glaucomatous trabecular meshwork, retina, and optic nerve damage in mice
by: Timur A. Mavlyutov, et al.
Published: (2022-05-01)

Intestinal S100/Calgranulin Expression in Cats with Chronic Inflammatory Enteropathy and Intestinal Lymphoma
by: Denise S. Riggers, et al.
Published: (2022-08-01)

Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.
by: Kyung-Hee Kim, et al.
Published: (2017-01-01)

La materia arturiana nella lirica antico-francese. Alcuni esempi
by: Margherita Bisceglia
Published: (2019-12-01)

Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells
by: Margherita Passariello, et al.
Published: (2020-08-01)

Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma
by: Romy M. Heilmann, et al.
Published: (2017-04-01)

Novel EDAS++ method: Interval type criteria and extension to EDAS
by: Štilić Anđelka
Published: (2020-01-01)

Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs
by: Jana Weinekötter, et al.
Published: (2023-11-01)

The Role of Calgranulin B Gene on the Biological Behavior of Squamous Cervical Cancer in vitro and in vivo [Retraction]
by: Zhang W, et al.
Published: (2022-05-01)

The Role of Calgranulin B Gene on the Biological Behavior of Squamous Cervical Cancer in vitro and in vivo [Corrigendum]
by: Zhang W, et al.
Published: (2021-11-01)

IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1
by: Bijoy Chellan, et al.
Published: (2014-03-01)

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
by: Margherita Passariello, et al.
Published: (2021-05-01)

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
by: Vincenzo Quagliariello, et al.
Published: (2021-07-01)

PPG and EDA dataset collected with Empatica E4 for stress assessment
by: Sara Campanella, et al.
Published: (2024-04-01)